NEOGEN CORPORATION RETENTION BONUS AWARD AGREEMENTRetention Bonus Award Agreement • July 30th, 2024 • Neogen Corp • In vitro & in vivo diagnostic substances
THIS AWARD AGREEMENT, dated as of October 26, 2023 (the “Grant Date”), is entered into by and between Neogen Corporation, a Michigan corporation (the “Company”), and David H. Naemura (the “Participant”). Capitalized terms have the meaning defined herein or as defined in the Plan, as applicable.
NEOGEN CORPORATION STOCK OPTION AWARD AGREEMENTStock Option Award Agreement • July 30th, 2024 • Neogen Corp • In vitro & in vivo diagnostic substances
THIS AWARD AGREEMENT, dated as of the Grant Date set forth above, is entered into by and between Neogen Corporation, a Michigan corporation (the “Company”), and the Participant set forth above. Capitalized terms have the meaning defined herein or as defined in the Plan, as applicable.
NEOGEN CORPORATION RESTRICTED SHARE UNIT AWARD AGREEMENTRestricted Share Unit Award Agreement • July 30th, 2024 • Neogen Corp • In vitro & in vivo diagnostic substances
THIS AWARD AGREEMENT, dated as of the Grant Date set forth above, is entered into by and between Neogen Corporation, a Michigan corporation (the “Company”), and the Participant set forth above. Capitalized terms have the meaning defined herein or as defined in the Plan, as applicable.
